Relationship Between Endothelial Dysfunction and the Outcomes After Atrial Fibrillation Ablation.
Keisuke OkawaMasahiro SogoTakeshi MorimotoRyu TsushimaYuya SudoEisuke SaitoMasatomo OzakiMasahiko TakahashiPublished in: Journal of the American Heart Association (2023)
Background Endothelial dysfunction (ED) is associated with cardiovascular events in patients with atrial fibrillation (AF). However, the utility of ED as a prognostic marker after AF ablation supplementary to the CHA 2 DS 2 -VASc score is unclear. This study aimed to investigate the relationship between ED and 5-year cardiovascular events in patients undergoing AF ablation. Methods and Results We conducted a prospective cohort study of patients who underwent a first-time AF ablation and for whom the endothelial function was assessed by the peripheral vascular reactive hyperemia index (RHI) before ablation. We defined ED as an RHI of <2.1. Cardiovascular events included strokes, heart failure requiring hospitalization, arteriosclerotic disease requiring treatment, venous thromboses, and ventricular arrhythmias or sudden cardiac death. We compared the 5-year incidence of cardiovascular events after AF ablation between those with and without ED. Among the 1040 patients who were enrolled, 829 (79.7%) had ED, and the RHI value was found to be associated with the CHA 2 DS 2 -VASc score ( P =0.004). The 5-year incidence of cardiovascular events was higher among patients with ED than those without ED (98 [11.8%] versus 13 [6.2%]; log-rank P =0.014). We found ED to be an independent predictor of cardiovascular events after AF ablation (hazard ratio [HR], 1.91 [95% CI, 1.04-3.50]; P =0.036) along with a CHA 2 DS 2 -VASc score of ≥2 (≥3 for women) (HR, 3.68 [95% CI, 1.89-7.15]; P <0.001). Conclusions The prevalence of ED among patients with AF was high. Assessing the endothelial function could enable the risk stratification of cardiovascular events after AF ablation.
Keyphrases
- cardiovascular events
- atrial fibrillation
- catheter ablation
- emergency department
- left atrial
- coronary artery disease
- heart failure
- left atrial appendage
- cardiovascular disease
- oral anticoagulants
- direct oral anticoagulants
- risk factors
- radiofrequency ablation
- percutaneous coronary intervention
- patients undergoing
- type diabetes
- combination therapy